Overexpression of β-Catenin decreases drug-mediated cytotoxicity and autophagy in breast cancer stem-like cells.43 This is fitting to our findings using mTOR inhibitors as the high expression of β-Catenin comprised the induction of autophagy as well. The gene discussed is MTOR; the disease is breast cancer.